陰道真菌傳染病全球市場：藥物類型、給藥途徑、分銷渠道、區域規模、份額、前景、機會分析2022-2028

Vaginal Fungi Infections Treatment Market, by Drug Type, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: 2022年05月23日 | 出版商:

Coherent Market Insights | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

陰道真菌感染市場的增長是由陰道真菌感染髮病率增加推動的。根據疾病控制和預防中心 (CDC) 的數據，美國每年約有 140 萬患者因陰道念珠菌病而被門診診斷。此外，根據多學科數字出版研究所（MDPI）2020 年 2 月發表的一篇文章，外陰陰道念珠菌病（VVC）是人類最常見的念珠菌感染，全球約有 75% 的女性受到影響。在他的一生中至少一次。

然而，治療陰道真菌感染的替代療法可能會阻礙市場增長。

本報告調查和分析了全球陰道真菌感染市場、市場促進者和抑制者、市場機會、COVID-19 影響、藥物類型、給藥途徑、分銷渠道和區域市場。它提供了分析、競爭狀況等。

熱圖分析
市場份額分析
- Pfizer Inc.
- Bausch Health Companies Inc
- ANI Pharmaceuticals, Inc.
- Hikma Pharmaceuticals Plc
- Lupin Limited
- Mycovia Pharmaceuticals, Inc.
- Glenmark Pharmaceuticals Limited
- Unique Pharmaceuticals
- PEPTONIC medical AB
- Aurobindo Pharma Limited
- Dr. Reddy's Laboratories
- SCYNEXIS, Inc.
- Analyst Views

第10章章節

簡介目錄

Product Code: CMI4271

A vaginal yeast infection is a fungal infection that causes irritation, discharge, and intense itchiness of the vagina and the vulva - the tissues at the vaginal opening. Vaginal fungi infection is also known as vaginal yeast infection, vulvovaginal candidiasis, candidal vaginitis or vaginal candidiasis, and it the second most common type of vaginal infection in the U.S., according the Centers for Disease Control and Prevention.

Market Dynamics

Rising incidence of vaginal fungi infections are driving vaginal fungi infections treatment market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), 2018, around 1.4 million outpatient visits occur for vaginal candidiasis every year in the U.S. Moreover, according to an article published in Multidisciplinary Digital Publishing Institute (MDPI) in February 2020, Vulvovaginal candidiasis (VVC) is the most prevalent human candidal infection and nearly 75% women across the globe are affected by it least once in their lifetime. Furthermore, according to the same source, around 8% women across the globe suffer from Recurrent Vulvovaginal Candidiasis (RVVC).

However, alternative therapies for vaginal fungi infections treatment can hinder the market growth. For instance, Nutrablast, a dedicated company in the dietary supplement and personal care offers Tea Tree Suppositories for vaginal fungi infections treatment. The product is natural tea tree oil to provide a balanced vaginal environment.

Key features of the study:

This report provides in-depth analysis of the global vaginal fungi infections treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global vaginal fungi infections treatment market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study are Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Inc., Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, and SCYNEXIS, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global vaginal fungi infections treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vaginal fungi infections treatment market.

Detailed Segmentation:

Global Vaginal Fungi Infections Treatment Market, By Drug Type:
- Fluconazole
- Nystatin
- Flucytosine
- Others
Global Vaginal Fungi Infections Treatment Market, By Route of Administration:
- Oral
- Topical
Global Vaginal Fungi Infections Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Vaginal Fungi Infections Treatment Market, By Region:
- North America
  - By Drug Type:
  - Fluconazole
  - Nystatin
  - Flucytosine
  - Others
  - By Route of Administration
  - Oral
  - Topical
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Drug Type:
  - Fluconazole
  - Nystatin
  - Flucytosine
  - Others
  - By Route of Administration
  - Oral
  - Topical
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Drug Type:
  - Fluconazole
  - Nystatin
  - Flucytosine
  - Others
  - By Route of Administration
  - Oral
  - Topical
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Drug Type:
  - Fluconazole
  - Nystatin
  - Flucytosine
  - Others
  - By Route of Administration
  - Oral
  - Topical
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Drug Type:
  - Fluconazole
  - Nystatin
  - Flucytosine
  - Others
  - By Route of Administration
  - Oral
  - Topical
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Drug Type:
  - Fluconazole
  - Nystatin
  - Flucytosine
  - Others
  - By Route of Administration
  - Oral
  - Topical
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Pfizer Inc.*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- Bausch Health Companies Inc
- ANI Pharmaceuticals, Inc.
- Hikma Pharmaceuticals Plc
- Lupin Limited
- Mycovia Pharmaceuticals, Inc.
- Glenmark Pharmaceuticals Limited
- Unique Pharmaceuticals
- PEPTONIC medical AB
- Aurobindo Pharma Limited
- Dr. Reddy's Laboratories
- SCYNEXIS, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Pipeline Analysis
Reimbursement Scenario
Epidemiology
Pest Analysis
Regulatory Scenario
New Product Launches
Collaborations and Agreements
Market Trends

4. Global Vaginal Fungi Infections Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Market Scenario
Impact of COVID-19 Market on the Vaginal Fungi Infections Treatment Products

5. Global Vaginal Fungi Infections Treatment Market, By Drug Type, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Fluconazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Nystatin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Flucytosine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Vaginal Fungi Infections Treatment Market, By Route of Administration, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Vaginal Fungi Infections Treatment Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

8. Global Vaginal Fungi Infections Treatment Market, By Region, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
North America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa

9. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bausch Health Companies Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- ANI Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Hikma Pharmaceuticals Plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Lupin Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mycovia Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Glenmark Pharmaceuticals Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Unique Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- PEPTONIC medical AB
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aurobindo Pharma Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dr. Reddy's Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- SCYNEXIS, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views